Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Mitoguazone MeSH Descriptor Data 2025


MeSH Heading
Mitoguazone
Tree Number(s)
D02.078.370.600
Unique ID
D008935
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D008935
Scope Note
Antineoplastic agent effective against myelogenous leukemia in experimental animals. Also acts as an inhibitor of animal S-adenosylmethionine decarboxylase.
Entry Term(s)
MGBG
Methyl-gag
Methylglyoxal Bis(guanylhydrazone)
NSC-32946
Pharm Action
Antineoplastic Agents
Enzyme Inhibitors
Registry Numbers
OD5Q0L447W
0
Related Numbers
459-86-9
CAS Type 1 Name
Hydrazinecarboximidamide, 2,2'-(1-methyl-1,2-ethanediylidene)bis-
Previous Indexing
Amidines (1973-1974)
Glyoxal (1973-1974)
Hydrazones (1973-1974)
Public MeSH Note
86; was see under GUANIDINES 1975-85
History Note
86(75); was see under GUANIDINES 1975-85
Date Established
1986/01/01
Date of Entry
1974/11/19
Revision Date
2013/07/08
Mitoguazone Preferred
Methyl-gag Related
NSC-32946 Narrower
page delivered in 0.158s